Adma Biologics ADMA Estimates

Analysts expect Adma Biologics, Inc. to report revenue of 145.85 M for Q3 26, against a range of 139.01 M to 152.70 M. The most recent reported quarter, Q2 26, came in at 124.39 M, a 6.8% miss against the 133.47 M consensus.

Analysts expect Adma Biologics, Inc. to report earnings per share of 0.19 for Q3 26, against a range of 0.17 to 0.21. The most recent reported quarter, Q2 26, came in at 0.16, a 5.9% miss against the 0.17 consensus.

https://data.businessquant.com/estimates?ticker=ADMA&mode=revenue&api_key=YOUR_API_KEY

import requests

url = "https://data.businessquant.com/estimates"
params = {"ticker": "ADMA", "mode": "revenue", "api_key": "YOUR_API_KEY"}

data = requests.get(url, params=params).json()

const res = await fetch("https://data.businessquant.com/estimates?ticker=ADMA&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();